Evidence map›Paper›PMID 19223462›Full record

ArticleMolecular and cellular biology2009

Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics.

David C Clarke, Meredith L Brown, Richard A Erickson, Yigong Shi, Xuedong Liu

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Engineering Approaches to Study Cellular Decision Making.Annual review of biomedical engineering · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLCγ1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  14. Measuring TGF-β Ligand Dynamics in Culture Medium.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

David C ClarkeDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309-0215, USA.
Meredith L Brown
Richard A Erickson
Yigong Shi
Xuedong Liu
Biological E (India) · INPrinceton University · USUniversity of Colorado Boulder · USUniversity of Colorado System · US

Funding

Quantitative Analysis of TGF-b/Smad Signaling DynamicsR01GM083172 · NIGMS · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2008 to 2011
$1.0M
NIGMS NIH HHS GM 083172NIGMS NIH HHS R01 GM083172
6 · The paper itself

Abstract

A cell's decision to growth arrest, apoptose, or differentiate in response to transforming growth factor beta (TGF-beta) superfamily ligands depends on the ligand concentration. How cells sense the concentration of extracellular bioavailable TGF-beta remains poorly understood. We therefore undertook a systematic quantitative analysis of how TGF-beta ligand concentration is transduced into downstream phospho-Smad2 kinetics, and we found that the rate of TGF-beta ligand depletion is the principal determinant of Smad signal duration. TGF-beta depletion is caused by two mechanisms: (i) cellular uptake of TGF-beta by a TGF-beta type II receptor-dependent mechanism and (ii) reversible binding of TGF-beta to the cell surface. Our results indicate that cells sense TGF-beta dose by depleting TGF-beta via constitutive TGF-beta type II receptor trafficking processes. Our results also have implications for the role of the TGF-beta type II receptor in disease, as tumor cells harboring TGF-beta type II receptor mutations exhibit impaired TGF-beta depletion, which may contribute to the overproduction of TGF-beta and a consequently poor prognosis in cancer.

Indexed as

AnimalsCell LineCulture MediaHumansNeoplasmsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IISignal TransductionSmad2 ProteinTransforming Growth Factor betaCulture MediaProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IISmad2 ProteinTransforming Growth Factor beta

Identifiers

PMID19223462
PMCPMC2668365
OpenAlexW2160355017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.